Anupam Rasayan India Acquires 47.95% Stake in Bliss GVS Pharma
Anupam Rasayan India Limited, along with its Person Acting in Concert (PAC), Mates Visa Consultancy Private Limited, has acquired a substantial stake in Bliss GVS Pharma Limited. The acquisition, made pursuant to a Share Purchase Agreement, has resulted in Anupam Rasayan India and its PAC holding 50.07% of the total share capital of Bliss GVS Pharma. Prior to this acquisition, their combined holding was 2.12%. The transaction involved the acquisition of 5,09,84,595 equity shares, representing 47.95% of the total voting capital. The total equity share capital of Bliss GVS Pharma considered for this acquisition was 10,63,30,472 shares as of September 28, 2026. This move signifies a significant change in the shareholding structure of Bliss GVS Pharma.
Key Highlights
- Anupam Rasayan India and PAC acquired 47.95% stake in Bliss GVS Pharma.
- Combined holding increased from 2.12% to 50.07% post-acquisition.
- Acquisition was made via Share Purchase Agreement.
- Total shares acquired amount to 5,09,84,595 equity shares.
- This is a substantial acquisition under SEBI (SAST) Regulations.
Price Impact
More from BLISSGVS